ACTRN12612001175864已完成未知
A study involving early breast cancer patients upon completion of active treatment to determine their views on a pilot breast cancer survivorship care plan designed for a New Zealand context.
Regional Cancer Treatment Service, MidCentral Health DHB0 个研究点目标入组 30 人开始时间: 2012年11月6日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Educational / counselling / training
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1.Females or males with histologically diagnosed early breast cancer who have undergone surgery alone or just completed adjuvant chemotherapy and/or radiation therapy if this is required. Patients can be receiving adjuvant hormone therapy or adjuvant herceptin therapy.
- •2.Age >=18 yrs.
- •3.Able to read English proficiently.
- •4.Willing and able to comply with all study requirements.
- •5.Signed, written informed consent.
排除标准
- •1.Patients who do not have a histological breast cancer diagnosis.
- •2.Patients with metastatic breast cancer.
- •3.Patients still receiving adjuvant chemotherapy or radiation therapy.
- •4.Life expectancy of less than 6 months.
- •5.Presence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule, including alcohol dependence or drug abuse.
研究者
相似试验
进行中（未招募）
1 期
Pivotal study in breast cancer patients investigating efficacy and safety of LA-EP2006 and Neulasta®Breast CancerEUCTR2012-002039-28-ESSandoz GmbH308
已完成
3 期
A study to evaluate the Efficacy and Safety of LA-EP2006 and Neulasta® in patients with breast cancer.CTRI/2012/10/003065Sandoz GmbH302
招募中
不适用
A study to estimate improvement in quality of life, cost effectiveness of radiotherapy in patients of breast cancer with bone metastases.CTRI/2018/03/012317Tata Memorial Hospital
招募中
2 期
Pre-operative phase II trial for breast cancer with nivolumab in combination with novel IO (BELLINI trial)breast cancerNL-OMON54814ederlands Kanker Instituut90
进行中（未招募）
1 期
Pre-operative study for breast cancer with nivolumab in combination with other therapyMedDRA version: 21.1Level: LLTClassification code 10006188Term: Breast cancer female NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006194Term: Breast cancer NOS stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006195Term: Breast cancer NOS stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10006196Term: Breast cancer NOS stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004188-30-NLKI-AV90